Stroke Rate after CABG vs PCI in over 10,000 Patients

Repeat revascularization rate has historically been the weak spot of PCI when compared against CABG: we are still unable to compete with a well done internal mammary artery graft connected to the anterior descending artery.

Tasa de stroke post cirugía vs angioplastia coronaria en un análisis de más de 10.000 pacientesHowever, repeat revascularization is the soft of end points commonly assessed in trials, and even though several studies have shown the kind of patients that most benefit from CABG in terms of death or infarction, stroke has traditionally been overlooked. Most likely, the reason we lack data on one of the hardest end points is because it is not as frequent, which is why we need a larger population, to be able to show significant differences between these strategies.

 

This pooled analysis including 11518 patients (5573 PCI and 5765 CABG) from 11 randomized studies, showed that at 5 years stroke rate is significantly lower with PCI. The advantage seems to be driven by periprocedural stroke common to CABG, seeing as from 30 days and up to 5 years after procedure curves remain parallel. This kind of strokes are associated to higher mortality post procedure.


Read also: Endovascular Therapy in Stroke: Much Evidence and Few Trained Operators.


The pooled analysis included old studies such as the ERACL, ARTS or MASS II, classic studies such as the SYNTAX or the FREEDOM, and more contemporary studies such as the EXCEL and NOBLE.

 

At 30 days, stroke rate was 0.4% in the PCI group, and 1.1% with CABG (HR 0.33, CI 95% 0.20 to 0.53; p<0.001).

 

At 5 year follow up, stroke rate continued to be significantly lower in the PCI group (2.6% vs. 3.2%; p=0.027), even though between day 31 and 5 years, the incidence was comparable (2.2% vs 2.1%; p=072). There were no significant interactions between baseline characteristics and stroke with the sole exception of diabetes, where patients receiving PCI were especially benefitted. (2.6% vs 4.9%).


Read also: The Dangerous Combination of Complex Angioplasty and High Bleeding Risk Seems to Have a Solution.


Patients suffering from stroke within 30 days after index procedure had higher mortality both with PCI (45.7% vs 11.1%, p<0.001) and CABG (41.5% vs. 8.9%, p<0.001).

 

Conclusion

This analysis is one of the largest and most representative randomized studies to compare PCI against CABG, and with a 5 year follow up it has shown that stroke is significantly lower in patients undergoing PCI, driven by a reduced risk within 30 days after procedure, seeing as after 30 days and up to 5 years later, curves remain identical. The greatest risk of stroke in CABG patients was observed with multiple vessels disease and diabetes. Presenting stroke increased mortality at follow up regardless the strategy.

 

Original title: Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.

Reference: Stuart J. Head et al. J Am Coll Cardiol 2018;72:386–98.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...